
|Articles|October 7, 2019
Patient outcomes and intraoperative use of phenylephrine/ketorolac 1%/0.3%
Author(s)Julianne Mobilian
ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.
Advertisement
Denise Visco, MD, conducted a retrospective chart analysis of patients who received phenylephrine and ketorolac (OMIDRIA) during surgery-here's what she found.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Lesion growth rate reduction tops retina specialists' geographic atrophy treatment priorities
3
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
4
ChatGPT-5 overestimates macular hole surgery success, study finds
5


























